GW Pharmaceuticals plc

GW Pharmaceuticals plc

GW was founded in 1998. GW Pharmaceuticals has "high" hopes that its products will help relieve the pain and muscle stiffness that have resulted from cancer, multiple sclerosis, and surgery. The company develops prescription medicinal drugs derived from an hybrid form of cannabis that doesn't cause a psychotropic high. GW's lead drug candidate is Sativex, a whole-plant cannabis extract delivered by an oral spray. Sativex has been approved in Canada for the treatment of pain caused by multiple sclerosis. The company has agreed to let Bayer market the drug in the UK and Canada.

Contact Details

Office Address

GW Pharmaceuticals plc
Porton Down Science Park
Salisbury, Wiltshire, UK SP40JQ
Phone: +44-1980-557-000
Fax: +44-1980-557-111

Executives

Executive Chairman

Geoffrey Guy

Managing Director

Justin Gover

Business Reviews for GW Pharmaceuticals plc

Related Companies